Medical Research News

RSS

More is better than less when it comes to physical activity and cardiovascular disease

In this interview, we speak to Esmée Bakker about her latest research which investigated the impact physical activity has on cardiovascular disease.

6 Jan 2022

Emergence of a new SARS-CoV-2 variant from Southern France

A new study has described the emergence of another new SARS-CoV-2 variant from south-eastern France with Cameroonian origin.

6 Jan 2022

Small molecule identified as a SARS-CoV-2 inhibitor

A new study published in iScience reports the results of a screening strategy to identify small molecules that target viral entry to block infection with this virus.

6 Jan 2022

Emotional response can fuel the spread of "fake news"

From Facebook feeds to questionable websites, so-called "fake news" is seemingly everywhere. When it comes to the misleading information, our emotional response to seeing it can actually further its spread, according to a Bowling Green State University researcher.

6 Jan 2022

Host kinase identified as an inhibition target for SARS-CoV-2

In this experiment, the chemical probe SGC-CK2-1 inhibited virus replication at nanomolar concentration, showing a highly selective effect on the kinase.

6 Jan 2022

Exploring a micro-simulation study on shielding individuals at high risk of COVID-19

A new study used an individual-based mathematical model to simulate the evolution of COVID-19 in a population, where a fraction of high-risk individuals is relocated to shielding residences having varying degrees of contact with others.

6 Jan 2022

Serological antibody response to SARS-CoV-2 infection at a population level

The scientists in this study used pooled convalescent serum to examine the serologic response in a population at risk of infection.

6 Jan 2022

Study finds all three proteins required for SARS-CoV-2 infection present in human glossopharyngeal and vagal nerves

Researchers explored the presence of coronavirus receptors in the glossopharyngeal and vagal cranial nerves.

6 Jan 2022

Melatonin found to inhibit SARS-CoV-2 entry into mice brains

New research recently unveiled the utility of melatonin and melatonin-derived medicines in reducing brain entry of severe acute respiratory syndrome coronavirus 2 and subsequently preventing long-term neurological consequences of coronavirus disease 2019.

6 Jan 2022

Comparison of neutralization of SARS-CoV-2 variants of concern Omicron and Delta

The purpose of this study was to determine the breadth of neutralizing activity generated by exposure to certain SARS-CoV-2 variants, vaccinations, or both.

6 Jan 2022

Does SARS-CoV-2 Omicron variant elicited neutralizing immunity enhance that elicited by the Delta variant?

In this paper, researchers studied whether the neutralizing immunity produced by Omicron also increases neutralizing immunity of the Delta variant.

6 Jan 2022

COVID boosters hinder SARS-CoV-2 Omicron

A new preprint research paper reports on the state of current knowledge as to the immune evasion capability of this variant, linking it to the type of vaccine used and the vaccination protocol.

6 Jan 2022

SARS-CoV-2 appears to persist in organs throughout the body for months

The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), leads to asymptomatic or mild symptoms in most cases. However, in a significant minority, it causes moderate or severe disease, with lung damage and sometimes multi-organ dysfunction, the origin of which is currently a matter of intense debate.

6 Jan 2022

Study examines if antidepressants can benefit patients with osteoarthritis

A clinical trial published in Arthritis & Rheumatology recently examined whether duloxetine, a medication that is prescribed to treat depression and may also reduce chronic pain, can benefit patients with hip or knee osteoarthritis.

6 Jan 2022

How diet, supplements and lifestyle changes can help battle COVID

A recent editorial in the journal Nutrients emphasizes how efficacious non-pharmacological interventions in conjunction with the promotion of healthy lifestyle and dietary patterns may improve overall health status and reduce the risk of infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as the potential adverse effects of coronavirus disease 2019 (COVID-19).

6 Jan 2022

Researchers set out to determine the brain and gravity’s effect on eyesight

Colonizing Mars is no longer solely the work of science fiction but a potential future option for people who desire to live among the weightless. For headline grabbers like Jeff Bezos, NASA and Elon Musk, space colonization - or space settlement, a preferred term recommended by Bill Nye - is a big goal for the 21st century.

6 Jan 2022

New engineered nanomaterials help capture chemotherapy drugs to avoid tissue damage

Standard chemotherapies may efficiently kill cancer cells, but they also pose significant risks to healthy cells, resulting in secondary illness and a diminished quality of life for patients. To prevent the previously unavoidable damage, researchers, led by Penn State, have developed a new class of nanomaterials engineered to capture chemotherapy drugs before they interact with healthy tissue.

6 Jan 2022

Neural connections of newborns with brain injuries impact childhood functional outcomes

A new UCSF study that mapped the neural connections of newborns with two different kinds of brain injuries found the maps looked very different - and were linked to significantly different developmental outcomes years later.

6 Jan 2022

Mental health conservatorships led to lengthy inpatient stays among homeless people with mental illness

At a time when public and private agencies and the legal system are grappling with how to best assist people who live at the intersection of homelessness and mental illness during a global pandemic, UCLA researchers have found mental health conservatorships for people with disabling, severe mental illness who are also homeless can result in lengthy psychiatric hospitalizations.

6 Jan 2022

LIVE-AIR trial demonstrates efficacy of Lenzilumab for treatment of COVID patients with decreased oxygen saturation

The LIVE-AIR phase 3 clinical trial is associated with early treatment of hyperinflammatory response with the humanized monoclonal antibody lenzilumab in COVID-19 patients with decreased oxygen saturation. The study results are posted to the medRxiv* preprint server.

6 Jan 2022

Medical Research News

More is better than less when it comes to physical activity and cardiovascular disease

Emergence of a new SARS-CoV-2 variant from Southern France

Small molecule identified as a SARS-CoV-2 inhibitor

Emotional response can fuel the spread of "fake news"

Host kinase identified as an inhibition target for SARS-CoV-2

Exploring a micro-simulation study on shielding individuals at high risk of COVID-19

Serological antibody response to SARS-CoV-2 infection at a population level

Study finds all three proteins required for SARS-CoV-2 infection present in human glossopharyngeal and vagal nerves

Melatonin found to inhibit SARS-CoV-2 entry into mice brains

Comparison of neutralization of SARS-CoV-2 variants of concern Omicron and Delta

Does SARS-CoV-2 Omicron variant elicited neutralizing immunity enhance that elicited by the Delta variant?

COVID boosters hinder SARS-CoV-2 Omicron

SARS-CoV-2 appears to persist in organs throughout the body for months

Study examines if antidepressants can benefit patients with osteoarthritis

How diet, supplements and lifestyle changes can help battle COVID

Researchers set out to determine the brain and gravity’s effect on eyesight

New engineered nanomaterials help capture chemotherapy drugs to avoid tissue damage

Neural connections of newborns with brain injuries impact childhood functional outcomes

Mental health conservatorships led to lengthy inpatient stays among homeless people with mental illness

LIVE-AIR trial demonstrates efficacy of Lenzilumab for treatment of COVID patients with decreased oxygen saturation

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News